Wei Guo Su
Net worth: 14 M $ as of 29/09/2026
Net worth: 14 M $ as of 29/09/2026
Currently, Wei Guo Su holds the position of Executive Director & Chief Scientific Officer at Hutchison China MediTech Ltd. and Chief Scientific Officer & Executive VP at Hutchison MediPharma Ltd. In his past career Dr. Su occupied the position of Director-Medicinal Chemistry Department at Pfizer Inc. He received a doctorate from Harvard University and an undergraduate degree from Fudan University.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 19/05/2026 | 4,749,220 ( 0.54% ) | 14 M $ | 29/09/2026 |
| Companies | Position | Start |
|---|---|---|
| HUTCHMED (CHINA) LIMITED | Chief Tech/Sci/R&D Officer | 31/12/2011 |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Discovers and develops innovative human therapeutics | Chief Tech/Sci/R&D Officer | 23/03/2010 |
| Companies | Position | End |
|---|---|---|
| PFIZER INC. | Corporate Officer/Principal | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 5 |
|---|---|
Pfizer Inc.
Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients | Health Technology |
HUTCHMED (China) Ltd.
HUTCHMED (China) Ltd. Pharmaceuticals: MajorHealth Technology Engages in the research and development, manufactures, and sells pharmaceuticals and health oriented consumer products | Health Technology |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Fudan University
Fudan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hutchison MediPharma Ltd.
Hutchison MediPharma Ltd. Medical SpecialtiesHealth Technology Discovers and develops innovative human therapeutics | Health Technology |
Select your edition
All financial news and data tailored to specific country editions